Viatris Inc.
- VTRS
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Generic Pharmaceuticals
- Specialty/Branded Drugs
$18.26
Today −2.12%Quote Oct 19, 2026, 08:00 PM UTC
+7.73%over the last month
Max drawdown −5.6%From 1-month high −2.1%3 months +3.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Viatris
Viatris Inc. operates as a global pharmaceutical and healthcare enterprise. Its business is structured across four primary geographic divisions: Developed Markets, Greater China, JANZ (Japan, Australia, New Zealand), and Emerging Markets.
Where the money comes from
Q2 2026 revenue $3.75B
- Brands$2.42B64.6%
- Generics$1.33B35.4%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
30,000
Founded
1961
Market value
$20.97B
Quote Oct 19
Floor
$18.18
0.5% below price
Resistance
$18.47
1.2% above price
Price vs analyst targets
13 analysts
Lowest target
$20.00Highest target
$26.00
$20.00Highest target
$26.00
- Price $18.26
- Average target $22.17
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 21% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VTRSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free